MSH2 and neoplasm: Joost et al. collected 14 CRCs with heterogeneous IHC staining patterns that affected at least one of the MMR proteins, that is, MLH1/PMS2 in three tumors, PMS2 in two tumors, MSH2/MSH6 in 10 tumors (of which two also expressed heterogeneity for MLH1/PMS2), and MSH6 in one tumor.